Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Thomas P. Thomopoulos, Anthi Bouhla, Sotirios G. Papageorgiou & Vasiliki Pappa. (2021) Chronic myelomonocytic leukemia - a review. Expert Review of Hematology 14:1, pages 59-77.
Read now
Read now
Merav Bar, Megan Othus, Hanahlyn M. Park, Vicky Sandhu, Xueyan Chen, Brent L. Wood & Elihu Estey. (2015) Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission. Leukemia & Lymphoma 56:11, pages 3109-3115.
Read now
Read now
Luana Fianchi, Marianna Criscuolo, Massimo Breccia, Luca Maurillo, Flavia Salvi, Pellegrino Musto, Giovanna Mansueto, Gianluca Gaidano, Carlo Finelli, Antonietta Aloe-Spiriti, Valeria Santini, Mariangelo Greco, Stefan Hohaus, Giuseppe Leone & Maria Teresa Voso. (2013) High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study. Leukemia & Lymphoma 54:3, pages 658-661.
Read now
Read now
David P. Steensma. (2008) The mosaic of Myeloid Neoplasia: Implications for Classification. Leukemia & Lymphoma 49:7, pages 1228-1229.
Read now
Read now
Ayalew Tefferi. (2008) Is chronic myelomonocytic leukemia more akin to myelodysplastic or myeloproliferative neoplasms and does it matter?. Leukemia & Lymphoma 49:7, pages 1225-1227.
Read now
Read now
Articles from other publishers (47)
Alexandra Rezazadeh, Michael Deininger & Ehab Atallah. (2023) Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia. Current Treatment Options in Oncology 24:8, pages 1036-1051.
Crossref
Crossref
Yanbo Nie, Liang Shao, Hong Zhang, Colin K. He, Hongyu Li, Junyan Zou, Long Chen, Huaiyue Ji, Hao Tan, Yani Lin & Kun Ru. (2022) Mutational landscape of chronic myelomonocytic leukemia in Chinese patients. Experimental Hematology & Oncology 11:1.
Crossref
Crossref
Danielle Hammond & Guillermo Montalban-Bravo. (2021) Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia. Current Hematologic Malignancy Reports 16:5, pages 405-417.
Crossref
Crossref
Jacqueline S. González, María Agustina Perusini, Ana L. Basquiera, Graciela Alfonso, Dorotea Fantl, Walter Macedo Lima, Elsa Nucifora, Carolina Lazzarino, Viviana Novoa, Marcela Cavalcanti de Andrade Silva, Irene B. Larripa, Vanderson Rocha, Jorge Arbelbide, Elvira D. R. P. Velloso & Carolina B. Belli. (2021) Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patients. Annals of Hematology 100:6, pages 1439-1449.
Crossref
Crossref
Luka Čemažar, Helena Podgornik, Njetočka Gredelj Šimec & Samo Zver. (2020) Successful Long-Term Treatment with Azacitidine in Patient with Chronic Myelomonocytic Leukemia. Hematology Reports 12:3, pages 8537.
Crossref
Crossref
Onyee Chan & Eric Padron. (2020) Moving towards a uniform risk stratification system in CMML - How far are we?. Best Practice & Research Clinical Haematology 33:2, pages 101131.
Crossref
Crossref
Tiffany N. Tanaka & Rafael Bejar. (2019) MDS overlap disorders and diagnostic boundaries. Blood 133:10, pages 1086-1095.
Crossref
Crossref
Sandrine Niyongere, Nolwenn Lucas, Jun-Min Zhou, Samer Sansil, Anthony D. Pomicter, Maria E. Balasis, John Robinson, Jodi Kroeger, Qing Zhang, Yu Long Zhao, Markus Ball, Rami Komrokji, Alan List, Michael W. Deininger, Brooke L. Fridley, Valeria Santini, Eric Solary & Eric Padron. (2018) Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML. Leukemia 33:1, pages 205-216.
Crossref
Crossref
Aziz Nazha & Mrinal M. Patnaik. (2018) Making Sense of Prognostic Models in Chronic Myelomonocytic Leukemia. Current Hematologic Malignancy Reports 13:5, pages 341-347.
Crossref
Crossref
Antònia Banús-Mulet, Amaia Etxabe, Josep Maria Cornet-Masana, Miguel Ángel Torrente, María Carmen Lara-Castillo, Laura Palomo, Meritxell Nomdedeu, Marina Díaz-Beyá, Francesc Solé, Benet Nomdedeu, Jordi Esteve & Ruth M. Risueño. (2018) Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML. Scientific Reports 8:1.
Crossref
Crossref
Florian Huemer, Lukas Weiss, Viktoria Faber, Daniel Neureiter, Alexander Egle, Klaus Geissler, Daniela Voskova, Armin Zebisch, Sonja Burgstaller, Angelika Pichler, Reinhard Stauder, Wolfgang Sperr, Alois Lang, Michael Pfeilstöcker, Sigrid Machherndl-Spandl, Margarete Stampfl, Richard Greil & Lisa Pleyer. (2018) Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia. Wiener klinische Wochenschrift 130:3-4, pages 115-125.
Crossref
Crossref
Sara Falk Jørgensen, Pernille Ravn, Søren Thorsen & Signe Westring Worm. (2017) Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway; a retrospective cohort study. BMC Cancer 17:1.
Crossref
Crossref
Francesco Onida. (2017) Models of Prognostication in Chronic Myelomonocytic Leukemia. Current Hematologic Malignancy Reports 12:6, pages 513-521.
Crossref
Crossref
Tamara K. Moyo & Michael R. Savona. (2017) Therapy for Chronic Myelomonocytic Leukemia in a New Era. Current Hematologic Malignancy Reports 12:5, pages 468-477.
Crossref
Crossref
Eric Solary & Raphael Itzykson. (2017) How I treat chronic myelomonocytic leukemia. Blood 130:2, pages 126-136.
Crossref
Crossref
Huanling Wu, Hui Sun, Zhifen Zhang, Xiangli Li, Yuantang Li, Li Li, Rui Xu, Zie Wang & Wenjun Tian. (2016) Routine blood examinations combined with morphological analysis for the diagnosis of myelodysplastic/myeloproliferative neoplasms. Oncology Letters 12:5, pages 4245-4251.
Crossref
Crossref
Alexandra M. Harrington, Lindsay A. Schelling, Atousa Ordobazari, Horatiu Olteanu, Paul R. Hosking & Steven H. Kroft. (2016) Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry. American Journal of Clinical Pathology 146:2, pages 170-181.
Crossref
Crossref
Nicolas Dumontier, Diane Rouzaud, Valérie Andrieu, Nadine Ajzenberg, Thomas Papo & Jean‐François Alexandra. (2016) Delirium revealing acute myeloid leukemia. Geriatrics & Gerontology International 16:5, pages 652-653.
Crossref
Crossref
Paola Minetto, Fabio Guolo & Maurizio Miglino. (2016) Chronic graft versus host disease as a weapon for treating chronic myelomonocytic leukemia. Leukemia Research 43, pages 49-50.
Crossref
Crossref
Piyanuch Kongtim, Uday Popat, Antonio Jimenez, Sameh Gaballa, Riad El Fakih, Gabriela Rondon, Julianne Chen, Carlos Bueso-Ramos, Gautam Borthakur, Naveen Pemmaraju, Guillermo Garcia-Manero, Hagop Kantarjian, Amin Alousi, Chitra Hosing, Paolo Anderlini, Issa F. Khouri, Partow Kebriaei, Borje S. Andersson, Betul Oran, Katayoun Rezvani, David Marin, Elizabeth J. Shpall, Richard E. Champlin & Stefan O. Ciurea. (2016) Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia. Biology of Blood and Marrow Transplantation 22:1, pages 47-53.
Crossref
Crossref
Xavier Calvo, Meritxell Nomdedeu, Rodrigo Santacruz, Núria Martínez, Dolors Costa, Arturo Pereira, Natalia Estrada, Blanca Xicoy, Jordi Esteve & Benet Nomdedeu. (2015) Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson prognostic score (MDAPS), CMML-specific prognostic scoring system (CPSS) and Mayo prognostic model. A detailed review of prognostic factors in CMML. Leukemia Research 39:11, pages 1146-1153.
Crossref
Crossref
Argiris Symeonidis, Anja van Biezen, Liesbeth de Wreede, Alfonso Piciocchi, Juergen Finke, Dietrich Beelen, Martin Bornhäuser, Jan Cornelissen, Liisa Volin, Ghulam Mufti, Yves Chalandon, Arnold Ganser, Benedetto Bruno, Dietger Niederwieser, Guido Kobbe, Rainer Schwerdtfeger, Theo de Witte, Marie Robin & Nicolaus Kröger. (2015) Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Trans. British Journal of Haematology 171:2, pages 239-246.
Crossref
Crossref
Victor T. Chang, Charles B. Scott, Melanie L. Gonzalez, Jan Einhorn, Houling Yan & Basil S. Kasimis. (2015) Patient-Reported Outcomes for Determining Prognostic Groups in Veterans With Advanced Cancer. Journal of Pain and Symptom Management 50:3, pages 313-320.
Crossref
Crossref
Aaron T. Gerds. (2014) I Walk the Other Line: Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndromes. Current Hematologic Malignancy Reports 9:4, pages 400-406.
Crossref
Crossref
Guilin Tang, Liping Zhang, Bin Fu, Jianhua Hu, Xinyan Lu, Shimin Hu, Ankita Patel, Maitrayee Goswami, Joseph D. Khoury, Guillermo Garcia-Manero, L. Jeffrey Medeiros & Sa A. Wang. (2014) Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution. American Journal of Hematology 89:8, pages 813-818.
Crossref
Crossref
Rena Buckstein, Robert Kerbel, Matthew Cheung, Yuval Shaked, Lisa Chodirker, Christina R. Lee, Martha Lenis, Cindy Davidson, Mary-Anne Cussen, Marciano Reis, Alden Chesney, Liying Zhang, Alexandre Mamedov & Richard A. Wells. (2014) Lenalidomide and metronomic melphalan for CMML and higher risk MDS: A phase 2 clinical study with biomarkers of angiogenesis. Leukemia Research 38:7, pages 756-763.
Crossref
Crossref
Mrinal M. Patnaik, Sameer A. Parikh, Curtis A. Hanson & Ayalew Tefferi. (2014) Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review. British Journal of Haematology 165:3, pages 273-286.
Crossref
Crossref
Lisa Pleyer, Ulrich Germing, Wolfgang R. Sperr, Werner Linkesch, Sonja Burgstaller, Reinhard Stauder, Michael Girschikofsky, Martin Schreder, Michael Pfeilstocker, Alois Lang, Thamer Sliwa, Dietmar Geissler, Konstantin Schlick, Gudrun Placher-Sorko, Georg Theiler, Josef Thaler, Martina Mitrovic, Daniel Neureiter, Peter Valent & Richard Greil. (2014) Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival. Leukemia Research 38:4, pages 475-483.
Crossref
Crossref
Sameer A. Parikh & Ayalew Tefferi. (2013) Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management. American Journal of Hematology 88:11, pages 967-974.
Crossref
Crossref
Elizabeth L Courville, Yue Wu, Jihen Kourda, Christine G Roth, Jillian Brockmann, Alona Muzikansky, Amir T Fathi, Laurence de Leval, Attilio Orazi & Robert P Hasserjian. (2013) Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia. Modern Pathology 26:6, pages 751-761.
Crossref
Crossref
Esperanza SuchUlrich GermingLuca MalcovatiJosé CerveraAndrea KuendgenMatteo G. Della PortaBenet NomdedeuLeonor ArenillasElisa LuñoBlanca XicoyMari L. AmigoDavid Valcarcel, Kathrin NachtkampIlaria AmbaglioBarbara Hildebrandt, Ignacio LorenzoMario CazzolaGuillermo Sanz. (2013) Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood 121:15, pages 3005-3015.
Crossref
Crossref
Sonja Burgstaller. (2013) Chronic myelomonocytic leukaemia: diagnosis and therapeutic implications. memo - Magazine of European Medical Oncology 6:1, pages 32-36.
Crossref
Crossref
H. Joachim Deeg, David T. Bowen, Steven D. Gore, Torsten Haferlach, Michelle M. Le Beau & Charlotte NiemeyerGuillermo Garcia-Manero. 2013. Myelodysplastic Syndromes. Myelodysplastic Syndromes
153
167
.
Gemma Osca-Gelis, Montserrat Puig-Vives, Marc Saez, David Gallardo, Francesc Solé & Rafael Marcos-Gragera. (2012) Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): A population-based study, 1993–2007. Leukemia Research 36:10, pages 1262-1266.
Crossref
Crossref
Sameer A. Parikh & Ayalew Tefferi*. (2012) Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management. American Journal of Hematology 87:6, pages 610-619.
Crossref
Crossref
Elizabeth Hyjek & James W. Vardiman. (2011) Myelodysplastic/myeloproliferative neoplasms. Seminars in Diagnostic Pathology 28:4, pages 283-297.
Crossref
Crossref
Thorsten BraunRaphael ItzyksonAline RennevilleBenoit de RenzisFrançois DreyfusKamel LaribiKrimo BouabdallahNorbert VeyAndrea TomaChristian RecherBruno RoyerBertrand JolyAnne VekhoffIngrid LafonLaurence Sanhes, Guillaume MeuriceCédric OréarClaude PreudhommeClaude GardinLionel AdesMichaela Fontenay, Pierre FenauxNathalie DroinEric Solary. (2011) Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial. Blood 118:14, pages 3824-3831.
Crossref
Crossref
Rubens Costa, Haifaa Abdulhaq, Bushra Haq, Richard K. Shadduck, Joan Latsko, Mazen Zenati, Folefac D. Atem, James M. Rossetti, Entezam A. Sahovic & John Lister. (2010) Activity of azacitidine in chronic myelomonocytic leukemia. Cancer 117:12, pages 2690-2696.
Crossref
Crossref
J. HALL & K. FOUCAR. (2010) Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders. International Journal of Laboratory Hematology 32:6p2, pages 559-571.
Crossref
Crossref
Alexander KohlmannVera GrossmannHans-Ulrich KleinSonja SchindelaTamara WeissBeray KazakFrank DickerSusanne SchnittgerMartin DugasWolfgang KernClaudia HaferlachTorsten Haferlach. (2010)
Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in
TET2
,
CBL
,
RAS
, and
RUNX1
. Journal of Clinical Oncology 28:24, pages 3858-3865.
Crossref
Crossref
Clara Ricci, Elisa Fermo, Stefania Corti, Mauro Molteni, Alessio Faricciotti, Agostino Cortelezzi, Giorgio Lambertenghi Deliliers, Miloslav Beran & Francesco Onida. (2010)
RAS
Mutations Contribute to Evolution of Chronic Myelomonocytic Leukemia to the Proliferative Variant
. Clinical Cancer Research 16:8, pages 2246-2256.
Crossref
Crossref
Lisa Pleyer, Daniel Neureiter, Victoria Faber & Richard Greil. 2010. Chronic Myeloid Neoplasias and Clonal Overlap Syndromes. Chronic Myeloid Neoplasias and Clonal Overlap Syndromes
223
233
.
P D Emanuel. (2008) Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia. Leukemia 22:7, pages 1335-1342.
Crossref
Crossref
A Orazi & U Germing. (2008) The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features. Leukemia 22:7, pages 1308-1319.
Crossref
Crossref
Francesco Onida & Miloslav Beran. (2008) Diagnosis and management of chronic myelomonocytic leukemia. Current Hematologic Malignancy Reports 3:1, pages 31-36.
Crossref
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:1, pages 46-53.
Crossref
Crossref
Benjamin H. Lee, Zuzana Tothova, Ross L. Levine, Kristina Anderson, Natalija Buza-Vidas, Dana E. Cullen, Elizabeth P. McDowell, Jennifer Adelsperger, Stefan Fröhling, Brian J.P. Huntly, Miloslav Beran, Sten Eirik Jacobsen & D. Gary Gilliland. (2007) FLT3 Mutations Confer Enhanced Proliferation and Survival Properties to Multipotent Progenitors in a Murine Model of Chronic Myelomonocytic Leukemia. Cancer Cell 12:4, pages 367-380.
Crossref
Crossref